YorkSpace has migrated to a new version of its software. Access our Help Resources to learn how to use the refreshed site. Contact diginit@yorku.ca if you have any questions about the migration.
 

A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain

dc.contributor.authorGoldberg, Robert J.
dc.contributor.authorKatz, Joel
dc.date.accessioned2011-05-19T15:10:56Z
dc.date.available2011-05-19T15:10:56Z
dc.date.issued2007
dc.description.abstractBetween 40% and 60% of Americans use complementary and alternative medicine to manage medical conditions, prevent disease, and promote health and well-being. Omega-3 polyunsaturated fatty acids (ω-3 PUFAs) have been used to treat joint pain associated with several inflammatory conditions. We conducted a meta-analysis of 17 randomized, controlled trials assessing the pain relieving effects of ω-3 PUFAs in patients with rheumatoid arthritis or joint pain secondary to inflammatory bowel disease and dysmenorrhea. Meta-analysis was conducted with Cochrane Review Manager 4.2.8. for six separate outcomes using standardized mean differences (SMDs) as a measure of effect size: (1) patient assessed pain, (2) physician assessed pain, (3) duration of morning stiffness, (4) number of painful and/or tender joints, (5) Ritchie articular index, and (6) nonselective nonsteroidal anti-inflammatory drug consumption. Supplementation with ω-3 PUFAs for 3–4 months reduces patient reported joint pain intensity (SMD: −0.26; 95% CI: −0.49 to −0.03, p = 0.03), minutes of morning stiffness (SMD: −0.43; 95% CI: −0.72 to −0.15, p = 0.003), number of painful and/or tender joints (SMD: −0.29; 95% CI: −0.48 to −0.10, p = 0.003), and NSAID consumption (SMD: −0.40; 95% CI: −0.72 to − 0.08, p = 0.01). Significant effects were not detected for physician assessed pain (SMD: −0.14; 95% CI: −0.49 to 0.22, p = 0.45) or Ritchie articular index (SMD: 0.15; 95% CI: − 0.19 to 0.49, p = 0.40) at 3–4 months. The results suggest that ω-3 PUFAs are an attractive adjunctive treatment for joint pain associated with rheumatoid arthritis, inflammatory bowel disease, and dysmenorrhea.en
dc.identifier.citationPain, 129(1-2), 210-223. (2007)
dc.identifier.urihttp://hdl.handle.net/10315/7974
dc.language.isoenen
dc.publisherElsevieren
dc.rights.articlehttp://www.sciencedirect.com/science?_ob=MImg&_imagekey=B6T0K-4N5CSS8-4-1&_cdi=4865&_user=866177&_pii=S0304395907000413&_origin=gateway&_coverDate=05%2F31%2F2007&_sk=998709998&view=c&wchp=dGLzVzb-zSkzS&md5=2d934a9e0cfa112d4e7e9c9708b072b7&ie=/sdarticle.pdf
dc.rights.journalhttp://www.elsevier.com/wps/find/journaldescription.cws_home/506083/description#descriptionen
dc.rights.publisherhttp://www.elsevier.comen
dc.subjectmeta-analysisen
dc.subjectinflammatory bowel diseaseen
dc.subjectdysmenorrheaen
dc.subjectRCTen
dc.subjectrheumatoid arthritisen
dc.subjectjoint painen
dc.subjectinflammationen
dc.subjectfish oilen
dc.subjectDHAen
dc.subjectEPAen
dc.subjectomega-3 polyunsaturated fatty acidsen
dc.titleA meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain
dc.typeArticleen

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
KAT093.pdf
Size:
1.3 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.83 KB
Format:
Item-specific license agreed upon to submission
Description: